---All---
  • ---All---
  • Accession
  • Catalog #

EYA2 Antibody (Center)Peptide Affinity Purified Rabbit Polyclonal Antibody (Pab)

Country
United States
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
AP17094c 0.1 mg 400 ul In Stock $ 255.00 Add to cart
AP17094c-ev20 20 ug 100 ul In Stock $ 95.00 Add to cart
  • Specification
  • Citiations : 0
  • Reviews
  • Protocols
  • Backgrounds

EYA2 Antibody (Center) - Product info

ApplicationWB
  • Applications Legend:
  • W=Western Blotting
  • IP=Immunoprecipitation
  • IHC-P=Immunohistochemistry (Paraffin)
  • IF-IC=Immunofluorescence (Immunocytochemistry)
  • F=Flow Cytometry
Primary AccessionO00167
Other AccessionNP_742108.2
ReactivityHuman
Concentration0.25 mg/ml
IsotypeRabbit Ig
Calculated MW59232 Da

EYA2 Antibody (Center) - Additional info

Gene ID 2139
Other Names
EYA2; EAB1; Eyes absent homolog 2
Target/Specificity
This EYA2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 215-244 amino acids from the Central region of human EYA2.
Dilution
WB~~1:100~500
Format
Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.
Storage
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Precautions
EYA2 Antibody (Center) is for research use only and not for use in diagnostic or therapeutic procedures.

EYA2 Antibody (Center) - Protein Information

Name EYA2
Synonyms EAB1
Function
Tyrosine phosphatase that specifically dephosphorylates 'Tyr-142' of histone H2AX (H2AXY142ph). 'Tyr-142' phosphorylation of histone H2AX plays a central role in DNA repair and acts as a mark that distinguishes between apoptotic and repair responses to genotoxic stress. Promotes efficient DNA repair by dephosphorylating H2AX, promoting the recruitment of DNA repair complexes containing MDC1. Its function as histone phosphatase probably explains its role in transcription regulation during organogenesis. Coactivates SIX1. Seems to coactivate SIX2, SIX4 and SIX5. Together with SIX1 and DACH2 seem to be involved in myogenesis. May be involved in development of the eye. Interaction with GNAZ and GNAI2 prevents nuclear translocation and transcriptional activity
Cellular Location
Cytoplasm. Nucleus.
Tissue Location
Highest expression in muscle with lower levels in kidney, placenta, pancreas, brain and heart

EYA2 Antibody (Center) - Related products

AP17094c: EYA2 Antibody (Center)

RI11886: EYA2 predesign siRNA

DC02495: Human EYA2 cDNA Clone

LY10493a: EYA2 Over-expression Lysate

AT1972a: EYA2 Antibody (monoclonal) (M04)

AJ1149b: CD11b/ITAM Antibody

AJ1277a: EYA2 Antibody

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

Thank you for your support.


Submit

Provided below are standard protocols that you may find useful for product applications.

BACKGROUND

This gene encodes a member of the eyes absent (EYA) family of proteins. The encoded protein may be post-translationally modified and may play a role in eye development. A similar protein in mice can act as a transcriptional activator. Alternative splicing results in multiple transcript variants, but the full-length natures of all of these variants have not yet been determined.

REFERENCES

Bailey, S.D., et al. Diabetes Care 33(10):2250-2253(2010) Rose, J.E., et al. Mol. Med. 16 (7-8), 247-253 (2010) : Joslyn, G., et al. Alcohol. Clin. Exp. Res. 34(5):800-812(2010) Talmud, P.J., et al. Am. J. Hum. Genet. 85(5):628-642(2009) Guo, J.T., et al. Zhonghua Zhong Liu Za Zhi 31(7):528-531(2009)